Anti-EDIL3 antibody (30-60) {FITC}

Referencia NB-22-57606-100

embalaje : 100ug

Solicitar más información

Contact local distributor :


Teléfono : +1 850 650 7790

General Info

Host: Rabbit
Applications: ELISA/IHC/IP/WB
Reactivity: Cat/Human/Monkey/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-EDIL3 (30-60) is suitable for use in ELISA, Immunohistochemistry, Immunoprecipitation and Western Blot research applications.
Clonality: Polyclonal
Conjugation: FITC
Isotype: IgG
Purification: Affinity Purified
Concentration: 0.69-0.70 µg/µl
Dilution Range: WB: 1:500
DB: 1:20, 000
ELISA: 1:20, 000
IP: 1:200
IHC: 1:50-1:150
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.

Information

Gene Symbol: Edil3
Gene ID: 13612
Uniprot ID: EDIL3_MOUSE
Immunogen Region: 30-60
Immunogen: Synthetic peptide taken within amino acid region 30-60 on Del-1 protein.

Description

Tissue Specificity Expressed in angioblasts and early endothelial cells. By embryonic day 13.5, also expressed in a restricted group of non-endothelial cells including chondrocytes and retinal neurons.
Function Promotes adhesion of endothelial cells through interaction with the alpha-v/beta-3 integrin receptor. Inhibits formation of vascular-like structures. May be involved in regulation of vascular morphogenesis of remodeling in embryonic development.
Protein Name Egf-Like Repeat And Discoidin I-Like Domain-Containing Protein 3
Developmentally-Regulated Endothelial Cell Locus 1 Protein
Integrin-Binding Protein Del1
Cellular Localisation Secreted
Alternative Antibody Names Anti-Egf-Like Repeat And Discoidin I-Like Domain-Containing Protein 3 antibody
Anti-Developmentally-Regulated Endothelial Cell Locus 1 Protein antibody
Anti-Integrin-Binding Protein Del1 antibody
Anti-Edil3 antibody
Anti-Del1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance